Articles

Results 1 to 5 of 29


Obviousness-Type Double Patenting Dangers in the U.S.

USA - January 31 2018 The Federal Circuit's decision in Gilead Sciences, Inc. v. Natco Pharma Ltd. introduced even more confusion in an already confusing area of the law…

Miklos Gaszner, Ph.D.

Worldwide Divisional Strategy Considerations

European Union, USA - January 31 2018 Dividing a single patent application into multiple patents is often essential for deriving maximum economic benefit from the disclosed inventions…

Miklos Gaszner, Ph.D.

Bolar Exemption in Europe and Asia

Asia-Pacific, European Union - December 19 2017 The Bolar exemption is governed by European Directive 2001/83/EC on the Community Code relating to medicinal products for human use. Article 10(6)…

Bolar Exemptions in North America

Canada, Mexico, USA - December 18 2017 Because approval by the U.S. Food and Drug Administration (FDA) is a long, sometimes arduous process, U.S. law provides a research or experimental use…

Worldwide Bolar-type Provisions

Global - December 18 2017 Many countries have exemptions for patent infringement for a product and/or process that is not being used for direct commercialization and profit…